Current Research Status of Metronomic Chemotherapy in Combination Treatment of Breast Cancer

por Liu, Jiaxuan, He, Maiyue, Wang, Zijing, Li, Qiao, Xu, Binghe
Publicado 2022

Improved survival in patients with isolated liver metastasis at initial diagnosis with surgery at primary and metastatic sites: A population‐based study in patients with breast can...

por Chai, Yue, Chen, Yujie, Liu, Jiaxuan, He, Maiyue, Jiang, Mingxia, Xu, Binghe, Li, Qiao
Publicado 2023

Pitfalls in the management of subglottic paragangliomas at unusual location: a case report and literature review

por Hu, Juanjuan, Wang, Haiyang, Chen, Jianli, Pan, Xuelin, Deng, Di, Zhuo, Lufang, Liu, Shixi, He, Maiyue, Chen, Fei, Yang, Hui
Publicado 2021

A phase II study of a doublet metronomic chemotherapy regimen consisting of oral vinorelbine and capecitabine in Chinese women with HER2‐negative metastatic breast cancer

por Chai, Yue, Liu, Jiaxuan, Jiang, Mingxia, He, Maiyue, Wang, Zijing, Ma, Fei, Wang, Jiayu, Yuan, Peng, Luo, Yang, Xu, Binghe, Li, Qiao
Publicado 2023

Eribulin combined with antiangiogenic agents in women with HER2-negative metastatic breast cancer: a retrospective multicenter study

por Jiang, Mingxia, Shao, Bin, Wan, Donggui, Liu, Jiaxuan, He, Maiyue, Chai, Yue, Sang, Die, Wang, Jiayu, Ma, Fei, Fan, Ying, Yuan, Peng, Xu, Binghe, Li, Qiao
Publicado 2023

Safety and efficacy study of oral metronomic capecitabine combined with pyrotinib in HER2-positive metastatic breast cancer: A phase II trial

por He, Maiyue, Liu, Jiaxuan, Wang, Zijing, Ma, Fei, Wang, Jiayu, Zhang, Pin, Li, Qing, Yuan, Peng, Luo, Yang, Fan, Ying, Mo, Hongnan, Lan, Bo, Li, Qiao, Xu, Binghe
Publicado 2023